Back

Optimization of antiplatelet therapy in patients with coronary artery disease and type 2 diabetes mellitus after percutaneous coronary interventions

24 June 2023 (14:30 - 15:15)
Organised by: Logo
Congress Presentation Part of: Coronary heart disease pathway Pharmacotherapy ACNAP Premium Access ACNAP Congress 2023 Association of Cardiovascular Nursing and Allied Professions (ACNAP)

About the speaker

Photo
Doctor Muyassar Mukhamedova

CENTER FOR THE DEVELOPMENT OF PROFESSIONAL QUALIFICATION OF MEDICAL WORKERS, Tashkent (Uzbekistan)

5 More presentations in this session

Presentation thumbnail
11-years of a nurse-led follow-up service for patients who have undergone percutaneous coronary intervention
Miss S. Harrison (London, GB)
Abstract Slides
Presentation thumbnail
Suboptimal self-care trajectories of patients with coronary heart disease call for multiple levels of interventions: results from a longitudinal survey study
Associate Professor B. Ingadottir (Reykjavik, IS)
Abstract
Presentation thumbnail
Factors affecting the occurrence of postoperative atrial fibrillation in cardiac surgery patients.
Doctor K. Lomper (Wroclaw, PL)
Abstract
Presentation thumbnail
Infective endocarditis in octogenarians: a retrospective study in a single, high-volume surgical centre
Mr M. Tamburini (Florence, IT)
Abstract Slides
Presentation thumbnail
Suture mediated closure after TAVI following haemostasis with the perclose vascular closure device a clinical nurse specialist experience
Ms V. Perovic (Belgrade, RS)

Access the full session

Session thumbnail
Coronary heart disease pathway

The Event

Event poster

ACNAP Congress 2023

24 June 2023 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Optimizing post-PCI therapy: ticagrelor, prasugrel, clopidogrel, and cilostazol reduce early MACE
21 March 2026
thumbnail
Congress Presentation
Exploring the unmet needs of cardiometabolic risk factors and medicines optimisation among post-myocardial infarction patients with diabetes
4 April 2025
thumbnail
Congress Presentation
Antithrombotic therapy in diabetes
26 August 2023
thumbnail
Congress Presentation
Impact of potent P2Y12 inhibitors in adverse events reduction in diabetic patients with Acute Coronary Syndromes. An analysis from ACHILLES Registry.
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources